• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自骨髓基质细胞系的可溶性因子增强前B细胞生成。

Pre-B cell generation potentiated by soluble factors from a bone marrow stromal cell line.

作者信息

Landreth K S, Dorshkind K

机构信息

Department of Microbiology, West Virginia University, Medical Center, Morgantown 26506.

出版信息

J Immunol. 1988 Feb 1;140(3):845-52.

PMID:3276783
Abstract

Two bone marrow stromal cell lines isolated from the adherent layer of a Dexter-type long term bone marrow culture differ markedly in their hemopoietic support capacity. S17 supports myelopoiesis and the differentiation of early B cell precursors into B lymphocytes while S10 supports myeloid cell differentiation and not B lymphopoiesis. The identification of a stromal cell line with B cell support capacity prompted an investigation of whether the effects of S17 were mediated via soluble factors. Results presented herein indicate that medium conditioned by S17 but not S10 contains an activity that can induce the expression of the 220,000 m.w. 14.8 antigen and cytoplasmic mu H chain of Ig in B lymphocyte progenitors that have not yet expressed these markers. Bone marrow cells were depleted of 14.8+, cytoplasmic mu+ pre-B cells on antibody-coated petri dishes. After 24-h liquid culture newly generated pre-B cells were enumerated as cells that expressed cytoplasmic mu H chain of Ig but not Ig L chains by immunofluorescence. Expression of Ly5(220) was monitored by 14.8 antibody binding. This pre-B cell differentiation activity was abrogated by digestion with pronase, aminopeptidase, or carboxypeptidase. Isoelectric focusing data revealed the activity to have isoelectric point of 5.9 to 6.2. S17-conditioned medium was fractionated using HPLC and each fraction tested for pre-B cell-generating activity. Fractions collected from a Superose 12 gel filtration column were found to have two peaks of activity associated with molecules of apparent m.w. of approximately 60,000 and 10,000. Virtually identical peaks of activity were observed when medium conditioned by heterogeneous stromal cell cultures was fractionated. Separation of S10-conditioned medium revealed no cryptic activity. S17-conditioned medium was further characterized by anion exchange chromatography and the majority of the pre-B cell generating activity shown to be associated with the void volume that eluted from a MonoQ column. These fractions were rechromatographed on Superose and the activity again found to be associated with two fractions corresponding to apparent m.w. of 60,000 and 10,000. The S17 pre-B cell differentiation activity appears to result from the presence of a novel molecule because other well characterized mediators had no activity in this short-term liquid culture system. No pre-B cell-generating activity was observed when IL-1 or conditioned medium containing IL-2, IL-3, or IL-4 (B cell stimulatory factor 1) were added to cultures.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

从德克斯特型长期骨髓培养物的贴壁层分离出的两种骨髓基质细胞系,其造血支持能力有显著差异。S17支持髓细胞生成以及早期B细胞前体向B淋巴细胞的分化,而S10支持髓样细胞分化但不支持B淋巴细胞生成。具有B细胞支持能力的基质细胞系的鉴定促使人们研究S17的作用是否通过可溶性因子介导。本文给出的结果表明,由S17而非S10条件培养的培养基含有一种活性物质,它能在尚未表达这些标志物的B淋巴细胞祖细胞中诱导220,000分子量的14.8抗原和Ig的细胞质μ重链的表达。在包被抗体的培养皿上,骨髓细胞中的14.8 +、细胞质μ + 前B细胞被清除。经过24小时液体培养后,新产生的前B细胞通过免疫荧光法被计为表达Ig的细胞质μ重链但不表达Ig轻链的细胞。Ly5(220)的表达通过14.8抗体结合来监测。这种前B细胞分化活性在用链霉蛋白酶、氨肽酶或羧肽酶消化后被消除。等电聚焦数据显示该活性的等电点为5.9至6.2。使用高效液相色谱法对S17条件培养的培养基进行分级分离,并对每个级分进行前B细胞生成活性测试。从Superose 12凝胶过滤柱收集的级分被发现有两个活性峰,与表观分子量约为60,000和10,000的分子相关。当对由异质性基质细胞培养条件培养的培养基进行分级分离时,观察到几乎相同的活性峰。对S10条件培养的培养基进行分离未发现隐匿活性。通过阴离子交换色谱法对S17条件培养的培养基进行进一步表征,结果表明大部分前B细胞生成活性与从MonoQ柱洗脱的空体积相关。这些级分在Superose上再次进行色谱分离,活性再次被发现与两个级分相关,其表观分子量分别为60,000和10,000。S17的前B细胞分化活性似乎源于一种新分子的存在,因为其他特征明确的介质在这个短期液体培养系统中没有活性。当将IL - 1或含有IL - 2、IL - 3或IL - 4(B细胞刺激因子1)的条件培养基添加到培养物中时,未观察到前B细胞生成活性。(摘要截断于400字)

相似文献

1
Pre-B cell generation potentiated by soluble factors from a bone marrow stromal cell line.来自骨髓基质细胞系的可溶性因子增强前B细胞生成。
J Immunol. 1988 Feb 1;140(3):845-52.
2
A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis.来自骨髓长期培养物的基质细胞系能够支持髓系造血和B淋巴细胞生成。
J Immunol. 1987 Feb 15;138(4):1082-7.
3
IL-1 inhibits B cell differentiation in long term bone marrow cultures.白细胞介素-1在长期骨髓培养中抑制B细胞分化。
J Immunol. 1988 Jul 15;141(2):531-8.
4
Bone marrow stromal cell regulation of B-lymphopoiesis. I. The role of macrophages, IL-1, and IL-4 in pre-B cell maturation.骨髓基质细胞对B淋巴细胞生成的调节。I. 巨噬细胞、白细胞介素-1和白细胞介素-4在B前体细胞成熟中的作用。
J Immunol. 1988 Sep 15;141(6):2016-26.
5
Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta.对重组小鼠白细胞介素-7有反应的正常B细胞前体以及转化生长因子-β对白细胞介素-7活性的抑制作用。
J Immunol. 1989 Jun 1;142(11):3875-83.
6
Functional characterization of two stromal cell lines that support B lymphopoiesis.两种支持B淋巴细胞生成的基质细胞系的功能特性
J Immunol. 1990 Jul 15;145(2):423-8.
7
Partial characterization of a novel stromal cell-derived pre-B-cell growth factor active on normal and immortalized pre-B cells.一种对正常和永生化前B细胞具有活性的新型基质细胞衍生前B细胞生长因子的部分特性分析。
Exp Hematol. 1988 Sep;16(8):718-26.
8
Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.介导B细胞生长及从单克隆抗CD3抗体刺激的T细胞分化的淋巴因子的特性分析
J Immunol. 1989 Apr 1;142(7):2343-51.
9
Detection and characterization of a B cell stimulatory factor (BSF-TC) derived from a bone marrow stromal cell line.源自骨髓基质细胞系的B细胞刺激因子(BSF-TC)的检测与特性分析
J Immunol. 1989 Jun 1;142(11):3894-900.
10
Identification of an IL-7-associated pre-pro-B cell growth-stimulating factor (PPBSF). I. Production of the non-IL-7 component by bone marrow stromal cells from IL-7 gene-deleted mice.一种白细胞介素-7相关的前B前体细胞生长刺激因子(PPBSF)的鉴定。I. 来自白细胞介素-7基因缺失小鼠的骨髓基质细胞产生非白细胞介素-7成分。
J Immunol. 1998 Mar 1;160(5):2272-9.

引用本文的文献

1
International Society for Cell and Gene Therapy Clinical Translation Committee recommendations on mesenchymal stromal cells in graft-versus-host disease: easy manufacturing is faced with standardizing and commercialization challenges.国际细胞和基因治疗学会临床转化委员会关于移植物抗宿主病中间充质基质细胞的建议:易于制造面临标准化和商业化的挑战。
Cytotherapy. 2024 Oct;26(10):1132-1140. doi: 10.1016/j.jcyt.2024.05.007. Epub 2024 May 9.
2
Non-cell-autonomous hedgehog signaling promotes murine B lymphopoiesis from hematopoietic progenitors.非细胞自主的 hedgehog 信号促进了造血祖细胞向小鼠 B 淋巴细胞的生成。
Blood. 2012 Jun 7;119(23):5438-48. doi: 10.1182/blood-2011-12-397976. Epub 2012 Apr 18.
3
Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.
从人类多能干细胞生成治疗性患者特异性血管母细胞和造血干细胞的挑战与策略。
Int J Dev Biol. 2010;54(6-7):965-90. doi: 10.1387/ijdb.093043ap.
4
Zebrafish kidney stromal cell lines support multilineage hematopoiesis.斑马鱼肾基质细胞系支持多谱系造血。
Blood. 2009 Jul 9;114(2):279-89. doi: 10.1182/blood-2009-02-203638. Epub 2009 May 11.
5
Expansion in vitro of adult murine hematopoietic stem cells with transplantable lympho-myeloid reconstituting ability.具有可移植淋巴细胞 - 髓系重建能力的成年小鼠造血干细胞的体外扩增。
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13648-53. doi: 10.1073/pnas.94.25.13648.
6
Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow.雌激素缺乏会刺激小鼠骨髓中的B淋巴细胞生成。
J Clin Invest. 1994 Sep;94(3):1090-7. doi: 10.1172/JCI117424.
7
Interleukin 7 production and function in stromal cell-dependent B cell development.白细胞介素7在基质细胞依赖性B细胞发育中的产生与功能
J Exp Med. 1989 Jul 1;170(1):333-8. doi: 10.1084/jem.170.1.333.
8
Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice.人干扰素调节因子1基因在转基因小鼠中的异常表达诱导B细胞群体的特异性耗竭。
Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):532-6. doi: 10.1073/pnas.88.2.532.
9
Highly restricted expression of a stromal cell determinant in mouse bone marrow in vivo.基质细胞决定簇在小鼠骨髓中的体内高度受限表达。
J Exp Med. 1992 Oct 1;176(4):927-35. doi: 10.1084/jem.176.4.927.